ReThink Medical
ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device. Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning. Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms. Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs. We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.
ReThink Medical
ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device. Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning. Our product, CorBand™ uses state of the art algorithms and artificial intelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms. Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs. We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy.
TL;DR
Product: CorBand — wrist-worn continuous physiologic monitor + ML analytics for heart-failure prediction
Headquarters: San Francisco, California, United States
Funding (reported): Total reported funding $5,460,000 (last funding date 2017-05-01)
Company Overview
Problem Domain
Heart-failure monitoring and prevention; remote patient physiologic monitoring
Founded
2010
Industry
Medical device; Digital health
Funding Track Record
$5,460,000.00
Last funding date reported as 2017-05-01; sources list investors including Terumo Corporation and Norwich Ventures.
Investor Signal
“Terumo Corporation and Norwich Ventures listed as investors”